Finance

Lists
Why is 300497 up 4,23%?
Dive Deeper
300497:SHE
Jiangxi Fushine Pharmaceutical Co Ltd
CN¥14,78
+4,23%
(+0,60) 1D
16 Okt., 12:16:34 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300497...
Open
CN¥14,18
High
CN¥14,92
Low
CN¥14,03
Mkt. cap
9,25 mjd
Avg. vol.
37,61 m
Volume
42,49 m
Dividend
0,34%
Quarterly dividend
CN¥0,01
Ex-dividend date
24 Aug. 2026
P/E ratio
63,30
52-wk high
CN¥24,18
52-wk low
CN¥9,72
EPS
CN¥0,23
Shares outstanding
538,65 m
No. of employees
2 k
Open
CN¥14,18
High
CN¥14,92
Low
CN¥14,03
Mkt. cap
9,25 mjd
Avg. vol.
37,61 m
Volume
42,49 m
Dividend
0,34%
Quarterly dividend
CN¥0,01
Ex-dividend date
24 Aug. 2026
P/E ratio
63,30
52-wk high
CN¥24,18
52-wk low
CN¥9,72
EPS
CN¥0,23
Shares outstanding
538,65 m
No. of employees
2 k
News stories
From web sources and news partners
About Jiangxi Fushine Pharmaceutical Co Ltd
CEO-
Employees1,66 k
Founded20 Mrt. 2002
Headquarters-
SectorPharmaceutical industry
Websitefushine.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
254,68 m
415,64 m
357,76 m
530,49 m
Cost of goods sold
247,32 m
318,51 m
220,70 m
331,53 m
Cost of revenue
247,32 m
318,51 m
220,70 m
331,53 m
Research and development expenses
14,18 m
15,40 m
12,98 m
22,08 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36,98 m
49,14 m
36,10 m
42,99 m
Operating expense
21,00 m
107,93 m
58,20 m
71,21 m
Total operating expenses
268,31 m
426,44 m
278,89 m
402,75 m
Operating income
-13,64 m
-10,80 m
78,87 m
127,74 m
Other non operating income
-3,94 m
5,39 m
-5,89 m
1,71 m
EBT including unusual items
-58,83 m
-3,56 m
59,20 m
111,14 m
EBT excluding unusual items
-26,33 m
-24,11 m
61,52 m
110,06 m
Income tax expense
-1,14 m
-8,28 m
-263,12 k
-1,51 m
Effective tax rate
1,93%
232,34%
-0,44%
-1,36%
Other operating expenses
-27,78 m
34,37 m
4,09 m
950,12 k
Net income
-55,84 m
7,73 m
61,20 m
115,75 m
Net profit margin
-21,93%
1,86%
17,11%
21,82%
Earnings per share
-
-
-
-
Interest and investment income
1,33 m
997,56 k
764,06 k
1,18 m
Interest expense
-9,91 m
-16,38 m
-12,22 m
-11,11 m
Net interest expenses
-8,57 m
-15,38 m
-11,46 m
-9,93 m
Depreciation and amortization charges
-
-
-
-
EBITDA
29,04 m
35,99 m
125,66 m
177,38 m
Gain or loss from assets sale
13,58 k
377,06 k
-
-2,64 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme